3401 Grays Ferry Avenue
About CARMA Therapeutics
CARMA Therapeutics is a biotechnology company founded in 2016 to bring the power of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA). The company’s proprietary technology was developed at the Center for Cellular Immunotherapy at the Perelman School of Medicine at the University of Pennsylvania. CARMA TherapeuticsSM is headquartered in Philadelphia, PA
Founders: Saar Gill and Michael Klichinsky
3 articles with CARMA Therapeutics
CARMA Therapeutics is based on technology from the Center for Cellular Immunotherapies at the University of Pennsylvania, and was spun out of the laboratory of Saar Gill, assistant professor of Hematology Oncology in the Perelman School of Medicine there.
BioSpace is proud to present its NextGen "Class of 2018," a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.